Gene Expression Network Analysis Identifies Potential Targets for Prevention of Preeclampsia

References

• Di Renzo GC, Fonseca E, Gratacos E; FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine. Good clinical practice advice: first trimester screening and prevention of pre-eclampsia in singleton pregnancy. Int J Gynaecol Obstet. 2019;144(3):325–329. doi:10.1002/ijgo.12741
   PubMed Web of Science ®Google Scholar
• Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213–220. doi:10.1038/hr.2016.126
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO recommendations: policy of interventionist versus expectant management of severe pre-eclampsia before term. Geneva; 2018.
   Google Scholar
• Garovic VD, White WM, Vaughan L, et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75(18):2323–2334. doi:10.1016/j.jacc.2020.03.028
   PubMed Web of Science ®Google Scholar
• Adank MC, Hussainali RF, Oosterveer LC, et al. Hypertensive disorders of pregnancy and cognitive impairment: a prospective cohort study. Neurology. 2021;96(5):e709–e18. doi:10.1212/WNL.0000000000011363
   PubMed Web of Science ®Google Scholar
• Davies EL, Bell JS, Bhattacharya S. Preeclampsia and preterm delivery: a population-based case-control study. Hypertens Pregnancy. 2016;35(4):510–519. doi:10.1080/10641955.2016.1190846
   PubMed Web of Science ®Google Scholar
• Thornburg KL, Drake R, Valent AM. Maternal hypertension affects heart growth in offspring. J Am Heart Assoc. 2020;9(9):e016538. doi:10.1161/JAHA.120.016538
   PubMed Web of Science ®Google Scholar
• Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30 Suppl A:S32–7. doi:10.1016/j.placenta.2008.11.009
   PubMed Web of Science ®Google Scholar
• Redman C. The six stages of pre-eclampsia. Pregnancy Hypertens. 2014;4(3):246. doi:10.1016/j.preghy.2014.04.020
   PubMedGoogle Scholar
• Kaartokallio T, Cervera A, Kyllonen A, et al. Gene expression profiling of pre-eclamptic placentae by RNA sequencing. Sci Rep. 2015;5:14107. doi:10.1038/srep14107
   PubMed Web of Science ®Google Scholar
• Ren Z, Gao Y, Gao Y, et al. Distinct placental molecular processes associated with early-onset and late-onset preeclampsia. Theranostics. 2021;11(10):5028–5044. doi:10.7150/thno.56141
   PubMed Web of Science ®Google Scholar
• Gong S, Gaccioli F, Dopierala J, et al. The RNA landscape of the human placenta in health and disease. Nat Commun. 2021;12(1):2639. doi:10.1038/s41467-021-22695-y
   PubMed Web of Science ®Google Scholar
• Rasmussen M, Reddy M, Nolan R, et al. RNA profiles reveal signatures of future health and disease in pregnancy. Nature. 2022;601(7893):422–427. doi:10.1038/s41586-021-04249-w
   PubMed Web of Science ®Google Scholar
• Xu H, Xie Y, Sun Y, et al. Integrated analysis of multiple microarray studies to identify potential pathogenic gene modules in preeclampsia. Exp Mol Pathol. 2021;120:104631. doi:10.1016/j.yexmp.2021.104631
   PubMed Web of Science ®Google Scholar
• Tenorio MB, Ferreira RC, Moura FA, et al. Cross-talk between oxidative stress and inflammation in preeclampsia. Oxid Med Cell Longev. 2019;2019:8238727. doi:10.1155/2019/8238727
   PubMed Web of Science ®Google Scholar
• Rong M, Yan X, Zhang H, et al. Dysfunction of decidual macrophages is a potential risk factor in the occurrence of preeclampsia. Front Immunol. 2021;12:655655. doi:10.3389/fimmu.2021.655655
   PubMed Web of Science ®Google Scholar
• Gebara N, Correia Y, Wang K, et al. Angiogenic properties of placenta-derived extracellular vesicles in normal pregnancy and in preeclampsia. Int J Mol Sci. 2021;22(10):5402. doi:10.3390/ijms22105402
   PubMed Web of Science ®Google Scholar
• Scaife PJ, Simpson A, Kurlak LO, et al. Increased placental cell senescence and oxidative stress in women with pre-eclampsia and normotensive post-term pregnancies. Int J Mol Sci. 2021;22(14):7295. doi:10.3390/ijms22147295
   PubMed Web of Science ®Google Scholar
• Hu X, Zhang L. Uteroplacental circulation in normal pregnancy and preeclampsia: functional adaptation and maladaptation. Int J Mol Sci. 2021;22(16):8622. doi:10.3390/ijms22168622
   PubMed Web of Science ®Google Scholar
• Nakashima A, Shima T, Tsuda S, et al. Aggrephagy deficiency in the placenta: a new pathogenesis of preeclampsia. Int J Mol Sci. 2021;22(5):2432. doi:10.3390/ijms22052432
   PubMed Web of Science ®Google Scholar
• Matsubara K, Matsubara Y, Uchikura Y, et al. Pathophysiology of preeclampsia: the role of exosomes. Int J Mol Sci. 2021;22(5):2572. doi:10.3390/ijms22052572
   PubMed Web of Science ®Google Scholar
• Qin L, Yang Q, Fei Z, et al. Expression of lncRNA TINCR in the placenta of patients with pre-eclampsia and its effect on the biological behaviours of trophoblasts. Zygote. 2021:1–9. doi:10.1017/S0967199421000290
   Web of Science ®Google Scholar
• Li XL, Zhang L, Hou B, et al. Expression of lncRNA MIR210HG in preeclampsia placental tissue and its functional analysis. Zhonghua Fu Chan Ke Za Zhi. 2021;56(6):425–433. doi:10.3760/cma.j.cn112141-20210118-00029
   PubMedGoogle Scholar
• Lekva T, Roland MCP, Estensen ME, et al. Dysregulated non-coding telomerase RNA component and associated exonuclease XRN1 in leucocytes from women developing preeclampsia-possible link to enhanced senescence. Sci Rep. 2021;11(1):19735. doi:10.1038/s41598-021-99140-z
   PubMed Web of Science ®Google Scholar
• He J, Chen M, Xu J, et al. Identification and characterization of Piwi-interacting RNAs in human placentas of preeclampsia. Sci Rep. 2021;11(1):15766. doi:10.1038/s41598-021-95307-w
   PubMed Web of Science ®Google Scholar
• Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17. doi:10.2202/1544-6115.1128
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Serebrova VN, Trifonova EA, Gabidulina TV, et al. [Detection of novel genetic markers of susceptibility to preeclampsia based on an analysis of the regulatory genes in the placental tissue]. Mol Biol (Mosk). 2016;50(5):870–879. Russian. doi:10.1134/S0026893316050162
   PubMed Web of Science ®Google Scholar
• Liu S, Jiang S, Huang L, et al. Expression of SASH1 in preeclampsia and its effects on human trophoblast. Biomed Res Int. 2020;2020:5058260. doi:10.1155/2020/5058260
   PubMed Web of Science ®Google Scholar
• Radulovich N, Pham NA, Strumpf D, et al. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Mol Cancer. 2010;9:24. doi:10.1186/1476-4598-9-24
   PubMed Web of Science ®Google Scholar
• Wang J, He Y, Zhang J-W, et al. SASH1 may interact with REK signaling pathways through MAP2K2 and MAP4K4. Basic Clin Med. 2014;34(11):1530–1536.
   Google Scholar
• Chen CP, Huang JP, Chu TY, et al. Human placental multipotent mesenchymal stromal cells modulate trophoblast migration via Rap1 activation. Placenta. 2013;34(10):913–923. doi:10.1016/j.placenta.2013.06.311
   PubMed Web of Science ®Google Scholar
• Zhou G, Li Z, Sun S, et al. TGF-beta1 alleviates HgCl2 induced apoptosis via P38 MAPK signaling pathway in human trophoblast cells. Toxicol in Vitro. 2019;61:104626. doi:10.1016/j.tiv.2019.104626
   PubMed Web of Science ®Google Scholar
• Li X, Wang Z, Liu G, et al. EIF3D promotes the progression of preeclampsia by inhibiting of MAPK/ERK1/2 pathway. Reprod Toxicol. 2021;105:166–174. doi:10.1016/j.reprotox.2021.09.006
   PubMed Web of Science ®Google Scholar
• Li MQ, Hou XF, Shao J, et al. The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy. Biol Reprod. 2010;82(5):968–979. doi:10.1095/biolreprod.109.080739
   PubMed Web of Science ®Google Scholar
• Tong J, Niu Y, Chen ZJ, et al. Comparison of the transcriptional profile in the decidua of early-onset and late-onset pre-eclampsia. J Obstet Gynaecol Res. 2020;46(7):1055–1066. doi:10.1111/jog.14257
   PubMed Web of Science ®Google Scholar
• Tsai K, Tullis B, Jensen T, et al. Differential expression of mTOR related molecules in the placenta from gestational diabetes mellitus (GDM), intrauterine growth restriction (IUGR) and preeclampsia patients. Reprod Biol. 2021;21(2):100503. doi:10.1016/j.repbio.2021.100503
   PubMed Web of Science ®Google Scholar
• Saad AF, Diken ZM, Kechichian TB, et al. Pravastatin effects on placental prosurvival molecular pathways in a mouse model of preeclampsia. Reprod Sci. 2016;23(11):1593–1599. doi:10.1177/1933719116648218
   PubMed Web of Science ®Google Scholar
• Saif J, Ahmad S, Rezai H, et al. Hydrogen sulfide releasing molecule MZe786 inhibits soluble Flt-1 and prevents preeclampsia in a refined RUPP mouse model. Redox Biol. 2021;38:101814. doi:10.1016/j.redox.2020.101814
   PubMed Web of Science ®Google Scholar
• Gao J, Shen J, Jiang Y, et al. Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia. Zhonghua Fu Chan Ke Za Zhi. 2014;49(1):22–25.
   PubMedGoogle Scholar
• Perales A, Delgado JL, De La Calle M, et al. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain). Ultrasound Obstet Gynecol. 2017;50(3):373–382. doi:10.1002/uog.17373
   PubMed Web of Science ®Google Scholar
• Mccarey C, Baert J, Mathey MP, et al. [Clinical value of angiogenic and anti-angiogenic marker assay in preeclampsia]. Rev Med Suisse. 2020;16(712):2031–2036. French
   PubMedGoogle Scholar
• Zeisler H, Llurba E, Chantraine FJ, et al. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Ultrasound Obstet Gynecol. 2019;53(3):367–375. doi:10.1002/uog.19178
   PubMed Web of Science ®Google Scholar
• Saleh L, Verdonk K, Jan Danser AH, et al. The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort. Eur J Obstet Gynecol Reprod Biol. 2016;199:121–126. doi:10.1016/j.ejogrb.2016.02.013
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1: plGFRatio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22. doi:10.1056/NEJMoa1414838
   PubMed Web of Science ®Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63(2):346–352. doi:10.1161/HYPERTENSIONAHA.113.01787
   PubMed Web of Science ®Google Scholar
• Rana S, Hacker MR, Modest AM, et al. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012;60(2):451–458. doi:10.1161/HYPERTENSIONAHA.112.195065
   PubMed Web of Science ®Google Scholar
• Liu X, Deng Q, Luo X, et al. Oxidative stress-induced Gadd45alpha inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia. J Matern Fetal Neonatal Med. 2016;29(23):3776–3785. doi:10.3109/14767058.2016.1144744
   PubMed Web of Science ®Google Scholar
• Shibuya M, Matsui H, Sasagawa T, et al. A simple detection method for the serum sFLT1 protein in preeclampsia. Sci Rep. 2021;11(1):20613. doi:10.1038/s41598-021-00152-6
   PubMed Web of Science ®Google Scholar
• Sun Y, Tan L, Neuman RI, et al. Megalin, proton pump inhibitors and the renin-angiotensin system in healthy and pre-eclamptic placentas. Int J Mol Sci. 2021;22(14):7407.
   PubMed Web of Science ®Google Scholar
• Zuo Q, Zou Y, Huang S, et al. Aspirin reduces sFlt-1-mediated apoptosis of trophoblast cells in preeclampsia. Mol Hum Reprod. 2021;27(1). doi:10.1093/molehr/gaaa089
   PubMed Web of Science ®Google Scholar